Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.

Author: LaneKeith, OnoSanta J

Paper Details 
Original Abstract of the Article :
Antihistamines constitute the first line of therapy for allergic conjunctivitis, and are safe and effective in relieving the signs and symptoms of ocular allergy. Despite this, they are less effective than some other drugs in relieving delayed symptoms of allergic conjunctivitis. Recent evidence sug...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038998/

データ提供:米国国立医学図書館(NLM)

Exploring the Effects of Antihistamines on Conjunctival Epithelium in Allergic Conjunctivitis

The world of allergy research is like a vast desert, full of challenges and mysteries. In the field of allergic conjunctivitis, we're always searching for ways to relieve the itchy, watery eyes that plague so many people. This study, published in 2011, delves into the effects of two antihistamines, olopatadine and alcaftadine, on the conjunctival epithelium, the thin layer of cells lining the inside of the eyelid. The researchers used a mouse model to study the effects of these drugs on delayed symptoms of allergic conjunctivitis. They found that both antihistamines showed promise in modifying the changes in the conjunctival epithelium associated with allergic conjunctivitis, particularly at the time points reflecting late-phase reactions. This study, using a well-established animal model, helps us understand the mechanisms behind antihistamines and how they might affect the delicate tissues of the eye.

Antihistamines: A New Perspective on Late-Phase Reactions

The findings of this study highlight the potential of antihistamines to address late-phase reactions in allergic conjunctivitis. This is important because these late-phase reactions are often more persistent and difficult to treat. By showing how these drugs can influence the conjunctival epithelium, the study suggests that antihistamines may be more effective than previously thought. This understanding could pave the way for new treatments that target specific aspects of allergic conjunctivitis.

Applying the Findings to Everyday Life

This research encourages us to be more aware of the role of antihistamines in treating allergic conjunctivitis. If you experience persistent eye symptoms, talk to your doctor about whether an antihistamine might be right for you. Also, remember that maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help boost your overall immune system and potentially reduce the severity of allergic reactions.

Dr. Camel's Conclusion

The study's findings are a bit like an oasis in the desert of allergy research - a promising new direction to explore! It's exciting to see how antihistamines could potentially play a larger role in managing the late-phase reactions of allergic conjunctivitis. This research encourages us to keep exploring new perspectives and approaches to conquer the challenges of allergic diseases.

Date :
  1. Date Completed 2011-04-25
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21340041

DOI: Digital Object Identifier

PMC3038998

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.